trial · primary record
CMTX-101
Persistent Infection
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 43 |
| Primary completion | 2025-11-14 |
| Primary endpoint | Number and % of participants experiencing adverse events following a single IV infusion of CMTX-101 |
| Registry ID | NCT06159725 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:47.106Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06159725
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.